David Schamis said in a post on X that his side was not the buyer in Hyperliquid Labs’ over-the-counter HYPE token deal, which was valued at $320 million. The statement came after an earlier report said HyperLabs, the development team behind Hyperliquid, had sold 3.75 million HYPE through an OTC transaction. Schamis’ post directly rejects any suggestion that he or his team took the other side of that sale. The update centers on the identity of the buyer in the reported transaction, while the previously reported sale of 3.75 million HYPE by HyperLabs remains unchanged in the information provided.
David Schamis said in a post on X that his side was not the buyer in Hyperliquid Labs’ $320 million over-the-counter HYPE token transaction.
An earlier report said HyperLabs, the development team behind Hyperliquid, sold 3.75 million HYPE through an OTC deal.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
